The Human Health and Performance Directorate (HH&P) is the primary organization focused on enhancing crew health and performance and mitigating the risks associated with human spaceflight. With three offices, three divisions and over 900 employees, all HH&P functions are ultimately aimed at achieving our mission: optimizing human health and performance throughout all phases of spaceflight
In January 2012, the Directorate underwent a reorganization to better align its goals and strategies with those of the NASA Agency and JSC. The result was a refined vision and mission, and revised goals, objectives, and strategies. One of the first changes implemented was to rename the directorate from Space Life Sciences to Human Health and Performance to better reflect our vision and mission.
The most significant change in the directorate from the previous strategy was the integration of the Human Research Program and Crew Health and Safety activities. This change enhanced integration of research and development with operations to better support human spaceflight and International Space Station (ISS) utilization. Today, HH&P is ideally positioned to enable a more effective and efficient approach to human system risk mitigation.
The Human Health and Performance goals are to:
Lead human exploration and ISS utilization;
Lead human health and performance internationally;
Excel in management and advancement of innovations in health and human system integration;
Expand relevance to life on Earth and create enduring support and enthusiasm for space exploration.
We will achieve our goals by providing the following functions:
Optimize the integrated human system risk management process and continue to use the system to prioritize risks and execute tasks;
Define, develop, and maintain core capabilities and competencies;
Expand and strengthen strategic relationships;
Define, communicate and implement a customer-focused business model within the directorate;
Improve our customer focus;
Enhance internal and external communication in terms meaningful to our stakeholders, customers, and the general public.
Visual Impairment Intracranial Pressure (VIIP) Syndrome was identified in 2005. It is currently NASA’s leading spaceflight-related health risk, and is more predominant among men than women in space. Here, NASA astronaut Karen Nyberg of NASA uses a fundoscope to image her eye while in orbit.
NASA
Related Documents
NASA Human Health and Performance Strategy 2012
Mar 14, 2023
PDF (275.59 KB)
Strategic Alliances Strategies and Processes Benchmarking Study 2009
Mar 14, 2023
PDF (985.59 KB)
NASA Space Life Sciences Strategy 2007
Mar 14, 2023
PDF (239.71 KB)
Astronauts’ bodies change in a variety of ways during spaceflight, and some experience impaired vision. NASA is working to understand and prevent these changes, which may also help us understand and prevent related vision changes on Earth.
Explore Human Health and Performance
Our Organization
Explore our organization's functions and services.
Leadership Team
Learn about the Human Health and Performance Directorate leaders.
Capabilities
All Human Health and Performance functions aim to achieve our mission, "HH&P capabilities enable optimization of human health and performance throughout all phases of spaceflight."
Products
Human Health and Performance provide unique products and services required to maintain astronaut health and performance during and after long-duration space exploration.
Human System Risks
Risk is inherent in human spaceflight. However, specific risks can and should be understood, managed, and mitigated to reduce threats posed to astronauts.
Education Outreach
HH&P offers a wide variety of educational opportunities ranging from short internships to in-depth research fellowships and NASA grants.